Skip to content
left end
left end
right end

Sickle Cell

Sickle Cell Disease (SCD) is a serious group of conditions which are inherited (genetic). It affects the red blood cells in the blood. Sickle cell anaemia is the name of a specific form of SCD in which there are two sickle cell genes. With SCD, the red blood cells have a tendency to go out of shape and become sickle-shaped (like a crescent moon) - instead of their normal disc shape. This can cause various problems. In between the episodes of illness, people with SCD feel well.

Diagnosis we see/treat

Sickle Cell (HbSS, HbSC, HbS O Arab, HbS D Punjab, HbS Lepore, HbSE, HbS Beta 0 Thalassaemia, HbS Beta + Thalassaemia, HbS HPFH, HbS: Variant, HbCC)

Diagnosis we do not see/treat

Sickle Cell Trait/Carrier

Further information on sickle cell trait/carrier:

Generally speaking; a patient with a diagnosis of sickle cell trait/carrier is well and their general health is unlikely to be affected, but it is important to know that their carrier status will remain the same for life.

Their carrier status has been inherited from one of their parents.

The patient should inform all medical/dental staff of their carrier status before they receive any medical treatment to prevent unnecessary blood tests. 

Family planning

If a patient is a known carrier of an unusual haemoglobin and are planning on having a baby and their partner does not know whether they are a carrier of an unusual haemoglobin, we recommend the partner gets a haemoglobinopathy screening test done. This is a free test which can be organised via the GP surgery.

If the partner is found to also carry the gene for an unusual haemoglobin, then the GP can refer the patients to a genetic counsellor, who can explain the risks to their children and what their options are.

Clinical guidelines

Sickle Cell Disease Guideline for Adults 

Patient leaflets

We have various patient information leaflets. Please contact us to find out more.

If you are looking for information on transition from paediatric to adult services, please visit our transition website.